How to treat attention-deficit hyperactivity disorder: Is there a conclusive answer?;Hvorledes skal ADHD/DAMP behandles? Har vi det endelige svar?

Ugeskrift for Laeger

Volumn 167, Issue 48, 2005, Pages 4555-4559

  Hansen, Line ^a   Thomsen, Per Hove ^a  

^a AARHUS UNIVERSITY HOSPITAL   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

DEXAMPHETAMINE; METHYLPHENIDATE; CENTRAL STIMULANT AGENT;

ATTENTION DEFICIT DISORDER; BEHAVIOR THERAPY; COMMUNITY CARE; CONTROLLED STUDY; HUMAN; OUTCOME ASSESSMENT; PREVALENCE; SCORING SYSTEM; SHORT SURVEY; ARTICLE; COMPARATIVE STUDY; FOLLOW UP; MULTIMODALITY CANCER THERAPY; PRESCHOOL CHILD; PROGNOSIS; PSYCHOLOGICAL ASPECT; TREATMENT OUTCOME;

ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY; BEHAVIOR THERAPY; CENTRAL NERVOUS SYSTEM STIMULANTS; CHILD, PRESCHOOL; COMBINED MODALITY THERAPY; DEXTROAMPHETAMINE; FOLLOW-UP STUDIES; HUMANS; METHYLPHENIDATE; PROGNOSIS; TREATMENT OUTCOME;

EID: 32944460025     PISSN: 00415782     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Short Survey

References (12)

1. www.laegemiddelstyrelsen.dk/statistik/forbrugsanalyse/ritalin/sept 2003
2. The MTA Cooperative Group. A 14-month randomized clinical trial of treatment strategies for attention deficit/hyperactivity disorder. Arch Gen Psychiatry 1999;56:1073-86.
3. The MTA Cooperative Group. National Institute of Mental Health Multimodal treatment study of ADHD follow-up: changes in effectiveness and growth after the end of treatment. Pediatrics 2004;113:762-9.
4. The MTA Cooperative Group. National Institute of Mental Health Multimodal treatment study of ADHD follow-up: 24 month outcomes of treatment strategies for attention-deficit/hyperactivity disorder. Pediatrics 2004;113:754-61.
5. Wells KC, Pelham WE, Kotkin RA et al. Psychosocial treatment strategies in the MTA study: rationale, methods and critical issues in design and implementation. J Abnorm Child Psychol 2000;28:483-505.
6. The MTA Cooperative Group. Moderators and mediators of treatment response for children with attention-deficit/hyperactivity disorder. Arch Gen Psychiatry 1999;56:1088-96.
7. Jensen PS, Hinshaw SP, Kraemer HC et al. ADHD comorbidity findings from the MTA study: comparing comorbid subgroups. J Am Acad Child Adolesc Psychiatry 2001;40:147-58.
8. Pelham WE. The NIMH multimodal treatment study for attention deficit hyperactivity disorder: just say yes to drugs alone? Can J Psychiatry 1999; 44:981-91.
9. Abikoff H, Hechtman L, Klein RG et al. Symptomatic improvement in children with ADHD treated with long-term methylphenidate and multimodal psychosocial treatment. J Am Acad Child Adolesc Psychiatry 2004;43:802-11.
10. Barkley RA. Commentary on the multimodal treatment study of children with ADHD. J Abnorm Child Psychol 2000;28:595-9.
11. Carey WB. What the multimodal treatment study of children with attention deficit/hyperactivity disorder did and did not say about the use of methylphenidate for attention deficits. Pediatrics 2000;105:863-4.
12. Pelham WE, Schnedler RW, Bologna NC et al. Behavioral and stimulant treatment of hyperactive children: a therapy study with methylphenidate probes in a within-subject design. J Appl Behav Anal 1980;13:221-36.